MedPath

A Clinical study to compare the effects of Ayurvedic drug Guggulu Rasayan over another Ayurvedic drug Vidangadi Loha with Honey water in Dyslipidemia (Medoroga)

Phase 2
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Registration Number
CTRI/2024/04/066337
Lead Sponsor
BVVS Ayurvedic Medical College and Hospital Bagalkot
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Having clinical features of Dyslipidemia and Medoroga

2. Serum lipid levels ranging

Serum Cholesterol (201mg/dl or more)

Serum Triglycerides (161mg/dl or more)

Serum HDL (below 41mg/dl

Serum LDL (131mg/dl or more)

Serum VLDL (41mg/dl or more)

All or any of these.

3. Patients between the ages from 20-60 years of either sex

Exclusion Criteria

1. Patients having Cardiac problem

2. Patients suffering with serious metabolic disorders like Diabetes Mellitus and HTN.

3. Pregnancy and Lactating Women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the parameters of Lipid profileTimepoint: After 60 days
Secondary Outcome Measures
NameTimeMethod
Prevention of Lifestyle disorders like Obeysity, Atherosclerosis, Cardiac AttacksTimepoint: After 120 days
© Copyright 2025. All Rights Reserved by MedPath